05/09/2024
3:20 PM | Dianthus Therapeutics, Inc. /DE/ (Filer)
Dianthus Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
05/09/2024
3:08 PM | Dianthus Therapeutics, Inc. /DE/ (Filer)
Dianthus Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/11/2024
3:05 PM | Dianthus Therapeutics, Inc. /DE/ (Filer)
Dianthus Therapeutics (Filer)
| Form DEF 14A | |
04/11/2024
3:09 PM | Dianthus Therapeutics, Inc. /DE/ (Filer)
Dianthus Therapeutics (Filer)
| Form DEFA14A | |
04/11/2024
3:10 PM | Dianthus Therapeutics, Inc. /DE/ (Filer)
Dianthus Therapeutics (Filer)
| Form ARS | |
04/01/2024
5:34 PM | Dianthus Therapeutics, Inc. /DE/ (Subject)
Dianthus Therapeutics (Subject)
Fairmount Funds Management LLC (Filed by)
| Form SC 13D/A | |
04/01/2024
5:21 PM | Dianthus Therapeutics, Inc. /DE/ (Issuer)
Dianthus Therapeutics (Issuer)
Fairmount Funds Management LLC (Reporting)
Kiselak Tomas (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
|
03/27/2024
11:15 PM | Dianthus Therapeutics, Inc. /DE/ (Filer)
Dianthus Therapeutics (Filer)
| Form EFFECT | |
03/21/2024
4:02 PM | Dianthus Therapeutics, Inc. /DE/ (Filer)
Dianthus Therapeutics (Filer)
| Form S-1/A | |
03/21/2024
4:10 PM | Dianthus Therapeutics, Inc. /DE/ (Filer)
Dianthus Therapeutics (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
02/02/2024
3:32 PM | BCLS Fund III Investments, LP (Filed by)
Dianthus Therapeutics, Inc. /DE/ (Subject)
Dianthus Therapeutics (Subject)
Dianthus Therapeutics, Inc. /DE/ (Subject)
Dianthus Therapeutics (Subject)
| Form SC 13G | |
01/31/2024
11:11 AM | Avidity Partners Management LP (Filed by)
Dianthus Therapeutics, Inc. /DE/ (Subject)
Dianthus Therapeutics (Subject)
| Form SC 13D | |
01/24/2024
6:02 PM | Dianthus Therapeutics, Inc. /DE/ (Issuer)
Dianthus Therapeutics (Issuer)
Fairmount Funds Management LLC (Reporting)
Harwin Peter Evan (Reporting)
Kiselak Tomas (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/24/2024
6:04 PM | Dianthus Therapeutics, Inc. /DE/ (Issuer)
Dianthus Therapeutics (Issuer)
MOULDER LEON O JR (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/24/2024
5:55 PM | Avidity Partners Management LLC (0001993910) (Reporting)
Avidity Partners Management LP (Reporting)
Dianthus Therapeutics, Inc. /DE/ (Issuer)
Dianthus Therapeutics (Issuer)
Gregory Michael David (Reporting)
Meng Lei (Reporting)
Witzke David Roy (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/24/2024
4:26 PM | Dianthus Therapeutics, Inc. /DE/ (Subject)
Dianthus Therapeutics (Subject)
Fairmount Funds Management LLC (Filed by)
| Form SC 13D/A | |
01/22/2024
6:34 AM | Dianthus Therapeutics, Inc. /DE/ (Filer)
Dianthus Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/08/2024
7:02 AM | Dianthus Therapeutics, Inc. /DE/ (Filer)
Dianthus Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/21/2023
4:08 PM | Dianthus Therapeutics, Inc. /DE/ (Filer)
Dianthus Therapeutics (Filer)
| Form S-1/A | |
11/13/2023
8:02 AM | Dianthus Therapeutics, Inc. /DE/ (Subject)
Dianthus Therapeutics (Subject)
FMR LLC (Filed by)
| Form SC 13G | |
10/25/2023
3:15 PM | Dianthus Therapeutics, Inc. /DE/ (Filer)
Dianthus Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/04/2023
3:55 PM | Dianthus Therapeutics, Inc. /DE/ (Filer)
Dianthus Therapeutics (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
09/28/2023
4:09 PM | Dianthus Therapeutics, Inc. /DE/ (Issuer)
Dianthus Therapeutics (Issuer)
Fairmount Funds Management LLC (Reporting)
Harwin Peter Evan (Reporting)
Kiselak Tomas (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/25/2023
3:15 PM | Dianthus Therapeutics, Inc. /DE/ (Issuer)
Dianthus Therapeutics (Issuer)
Randhawa Simrat (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/21/2023
3:34 PM | Dianthus Therapeutics, Inc. /DE/ (Subject)
Dianthus Therapeutics (Subject)
Viridian, LLC (Filed by)
| Form SC 13D | |
09/21/2023
3:23 PM | Dianthus Therapeutics, Inc. /DE/ (Issuer)
Dianthus Therapeutics (Issuer)
Fairmount Funds Management LLC (Reporting)
Harwin Peter Evan (Reporting)
Kiselak Tomas (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/21/2023
3:32 PM | Dianthus Therapeutics, Inc. /DE/ (Subject)
Dianthus Therapeutics (Subject)
Fairmount Funds Management LLC (Filed by)
| Form SC 13D | |
09/21/2023
3:15 PM | Dianthus Therapeutics, Inc. /DE/ (Subject)
Dianthus Therapeutics (Subject)
Venrock Healthcare Capital Partners III, L.P. (Filed by)
| Form SC 13G | |
09/21/2023
3:15 PM | 5AM Partners VII, LLC (Filed by)
Dianthus Therapeutics, Inc. /DE/ (Subject)
Dianthus Therapeutics (Subject)
| Form SC 13G | |
09/20/2023
8:50 PM | Dianthus Therapeutics, Inc. /DE/ (Filer)
Dianthus Therapeutics (Filer)
| Form 8-K/A | |
09/15/2023
3:56 PM | Atlas Venture Fund X, L.P. (Filed by)
Dianthus Therapeutics, Inc. /DE/ (Subject)
Dianthus Therapeutics (Subject)
| Form SC 13D/A | |
09/13/2023
8:56 PM | Avidity Partners Management LP (Reporting)
Dianthus Therapeutics, Inc. /DE/ (Issuer)
Dianthus Therapeutics (Issuer)
Meng Lei (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/13/2023
8:31 PM | Avidity Partners Management LP (Reporting)
Dianthus Therapeutics, Inc. /DE/ (Issuer)
Dianthus Therapeutics (Issuer)
Meng Lei (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
09/13/2023
7:45 PM | Dianthus Therapeutics, Inc. /DE/ (Issuer)
Dianthus Therapeutics (Issuer)
Savitz Ryan (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
09/13/2023
7:46 PM | Dianthus Therapeutics, Inc. /DE/ (Issuer)
Dianthus Therapeutics (Issuer)
MOULDER LEON O JR (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
09/13/2023
7:46 PM | Dianthus Therapeutics, Inc. /DE/ (Issuer)
Dianthus Therapeutics (Issuer)
Violin Jonathan (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
09/13/2023
7:47 PM | CARR EDWARD (Reporting)
Dianthus Therapeutics, Inc. /DE/ (Issuer)
Dianthus Therapeutics (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
09/13/2023
7:48 PM | Dianthus Therapeutics, Inc. /DE/ (Issuer)
Dianthus Therapeutics (Issuer)
Veness Adam M (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
09/13/2023
7:50 PM | Dianthus Therapeutics, Inc. /DE/ (Issuer)
Dianthus Therapeutics (Issuer)
Randhawa Simrat (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
09/13/2023
7:51 PM | Dianthus Therapeutics, Inc. /DE/ (Issuer)
Dianthus Therapeutics (Issuer)
Garcia Marino (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
09/13/2023
7:52 PM | Dianthus Therapeutics, Inc. /DE/ (Issuer)
Dianthus Therapeutics (Issuer)
Soteropoulos Paula (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
Biden Nomination CANCELED? (Ad) The Hill just published that Joe Biden has received enough delegates to…“clinch the Democratic presidential nomination and all but guaranteeing he will face off against former President Trump again in November.”
Why is he all BUT guaranteed the Democratic nomination, in their words? I believe I have the terrifying answer right here. |
09/13/2023
7:55 PM | Dianthus Therapeutics, Inc. /DE/ (Issuer)
Dianthus Therapeutics (Issuer)
Fairmount Funds Management LLC (Reporting)
Harwin Peter Evan (Reporting)
Kiselak Tomas (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
09/13/2023
8:13 PM | Dianthus Therapeutics, Inc. /DE/ (Issuer)
Dianthus Therapeutics (Issuer)
MOULDER LEON O JR (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/13/2023
8:14 PM | Dianthus Therapeutics, Inc. /DE/ (Issuer)
Dianthus Therapeutics (Issuer)
McGeorge Anne (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/13/2023
8:16 PM | Dianthus Therapeutics, Inc. /DE/ (Issuer)
Dianthus Therapeutics (Issuer)
Soteropoulos Paula (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/13/2023
8:17 PM | Dianthus Therapeutics, Inc. /DE/ (Issuer)
Dianthus Therapeutics (Issuer)
Lawton Alison Frances (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/13/2023
8:17 PM | Dianthus Therapeutics, Inc. /DE/ (Issuer)
Dianthus Therapeutics (Issuer)
Fairmount Funds Management LLC (Reporting)
Harwin Peter Evan (Reporting)
Kiselak Tomas (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/13/2023
8:25 PM | Dianthus Therapeutics, Inc. /DE/ (Issuer)
Dianthus Therapeutics (Issuer)
Violin Jonathan (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/12/2023
3:05 PM | Dianthus Therapeutics, Inc. /DE/ (Filer)
Dianthus Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/08/2023
4:19 PM | Magenta Therapeutics, Inc. (Filer)
Dianthus Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/31/2023
8:00 AM | Magenta Therapeutics, Inc. (Subject)
Dianthus Therapeutics (Subject)
| Form 425 | |
08/03/2023
7:01 AM | Magenta Therapeutics, Inc. (Filer)
Dianthus Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
08/01/2023
11:15 PM | Magenta Therapeutics, Inc. (Filer)
Dianthus Therapeutics (Filer)
| Form EFFECT | |
08/01/2023
3:42 PM | Magenta Therapeutics, Inc. (Filer)
Dianthus Therapeutics (Filer)
| Form 424B3 | |
07/17/2023
8:30 AM | Magenta Therapeutics, Inc. (Filer)
Dianthus Therapeutics (Filer)
| Form S-4/A | |
06/22/2023
4:23 PM | Magenta Therapeutics, Inc. (Filer)
Dianthus Therapeutics (Filer)
| Form S-4/A | |
